[Effect of treatment with cimetidine and ranitidine on biological availability and circulatory effects of propranolol].
D000328:Adult; D001682:Biological Availability; D002927:Cimetidine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000378:metabolism*; D011899:Ranitidine / Q000627:therapeutic use*
D002927:Cimetidine; D011899:Ranitidine; D011433:Propranolol
Wpływ leczenia cymetydyna i ranitydyna na biodostepność i efekty krazeniowe propranololu.